Akari Therapeutics Plc · NASDAQ:AKTX
Patel Samir Rashmikant received 8,536 Akari Therapeutics Plc shares as an award (Form 4)
Traded Aug 18 to Oct 5, 2026 · Filed Oct 16, 2026
From Aug 18 to Oct 5, 2026, Patel Samir Rashmikant (Director) received 8,536 Akari Therapeutics Plc shares as an award at US$7.90 for US$67,426, leaving 12,102 shares. Filed Oct 16, 2026 (Form 4).
- Awarded
- 8,536 shares
- Price
- US$7.90
- Value
- US$67,426
- Holding after
- 12,102 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 18, 2026 | American Depositary Shares representing Ordinary Shares | Award | 6,300 | US$7.90 | 9,866 | Direct |
| Oct 5, 2026 | American Depositary Shares representing Ordinary Shares | Award | 2,236 | US$7.90 | 12,102 | Direct |
Source
Download original · View original at SEC